C1QTNF3 and diabetes mellitus: The aims of the current study were: (1) to determine whether CTRP3 modulates the barrier pathophysiological process of iBRB in NPDR, mitigating diabetes-induced retinal vascular permeability, and if so, (2) to determine the responsible mechanisms involved.